Mark Newcomer
President and Chief Executive Officer
Replay available
Paysign, Inc. (NASDAQ: PAYS) Q1 2025 earnings conference call, held 2025-05-08. Replay captured from the company's public earnings webcast.

President and Chief Executive Officer
Chief Financial Officer
Good afternoon. My name is Chelsea and I will be your conference operator today. At this time, I would like to welcome everyone to the Paysign, Inc. first quarter 2025 earnings conference call. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question at that time, please press star 1 on your telephone keypad. To remove your question, you may press star 2. As a reminder, this conference is being recorded. The comments on today's call regarding Paysign's financial results will be on a GAAP basis unless otherwise noted. Paysign's earnings release was disseminated to the SEC earlier today and can be found on the investor relations section of our website, Paysign.com, which includes reconciliations of non-GAAP measures to GAAP reported amounts. Additionally, as set forth in more detail in our earnings release, I would like to remind everyone that today's call will include forward-looking statements regarding Paysign's future performance. Actual performance could differ materially from these forward-looking statements. Information about the factors that could affect future performance is summarized at the end of PaySign's earnings release and in our recent SEC filings. Lastly, a replay of this call will be available until August 8, 2025. Please see PaySign's first quarter 2025 earnings call announcement for details on how to access the replay. It is now my pleasure to turn the call over to Mr. Mark Newcomer, CEO. Please go ahead. Thank you, Chelsea, and good afternoon, everyone. We appreciate you joining us today to go over our first quarter 2025 results. I'm Mark Newcomer, President and Chief Executive Officer, and I'm joined by our CFO, Jeff Baker. Also with us for Q&A portion are Matt Turner, President of Patient Affo...